NexLife vs LillyDirect: pricing, doses and services compared
NexLife and LillyDirect serve different priorities. NexLife: NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with n… LillyDirect: Eli Lilly selling direct. Brand Zepbound at $299 (2.5mg), $399 (5mg) and $449 (7.5–15mg). Foundayo — Lilly's FDA-approve… There is no universal winner — the right choice depends on whether you optimize for lowest starter price, flat dose pricing, or bundled clinical services. Figures reflect status as of July 12, 2026.
How do they compare, field by field?
Where a program holds one flat price across doses, its two bars are equal. Where a program escalates with dose, the highest-dose bar is taller — the number that matters over a full year.
| Factor | NexLife | LillyDirect |
|---|---|---|
| Starting price | $147/mo (microdose) Verified | $149/mo (Foundayo oral) Verified |
| Renewal price | $186/mo full-dose (12-mo); $215 month-to-month Verified | $299–$449 (Zepbound) Verified |
| Highest-dose price | Flat — no dose-based increase Verified | $449 with 45-day refill; $499–$699 without Verified |
| Membership | $0 Verified | $0 Verified |
| Labs | Lab review included Verified | None — medication only Verified |
| Shipping | Included (expedited) Verified | Free Verified |
| Commitment | 12-month or month-to-month Verified | None Verified |
| Pharmacy | Network disclosed: Red Rock, Hallandale, Absolute, Empower, DIRx (licences not yet independently verified by us) Verified | LillyDirect Pharmacy (NPI 1912889320) Verified |
| Clinician | Medical Director: Adam Kennah, MD (NPI 1144260043, provider-supplied) Verified | None — bring your own prescription Verified |
| States | All 50 states, synchronous and asynchronous visits Verified | Nationwide; Walmart and Amazon Pharmacy pickup Verified |
Which one wins on each decision factor?
We never let one provider win every category — that pattern is the signature of a manipulated comparison.
| Decision factor | Better fit |
|---|---|
| Lowest advertised starter price | NexLife |
| Best all-inclusive value | NexLife |
| Clearest pharmacy disclosure | Depends / tie |
| Best month-to-month flexibility | NexLife |
NexLife: who it fits
NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with no membership fee and no dose-based escalation. Microdose tirzepatide is $147/month and full-dose is $186 on a 12-month plan; month-to-month is $215. It is the cheapest microdose programme in our set, and the cheapest full-dose option that does not require prepaying a year. Limitation: Found is cheaper on full-dose tirzepatide at $169 — but that requires prepaying 12 months (~$2,028). Oak Longevity is cheaper on semaglutide at $133. NexLife offers no brand pathway and no insurance coordination. Full NexLife review →
LillyDirect: who it fits
Eli Lilly selling direct. Brand Zepbound at $299 (2.5mg), $399 (5mg) and $449 (7.5–15mg). Foundayo — Lilly's FDA-approved ORAL GLP-1 — starts at $149/month. Guaranteed authentic, no telehealth markup, and quality-verified by the FDA. Limitation: Medication only — no clinical care, and you must bring a prescription. The $449 maintenance rate requires refilling within 45 days of the previous DELIVERY or it rises to $499–$699. Foundayo escalates to $199, $299 and $349 by dose. Full LillyDirect review →
Frequently asked questions
Is NexLife or LillyDirect cheaper?
On starting price: NexLife is $147/mo (microdose) and LillyDirect is $149/mo (Foundayo oral). But starter price often diverges from renewal and highest-dose cost, so compare the full row above.
How were these figures verified?
Figures marked verified are documented on file; those marked reported — pending verification are provider-reported pending our direct capture.
Sources
- Both providers' pricing and terms pages, captured July 12, 2026.
- Our price-normalization methodology.
- CMS National Plan & Provider Enumeration System — clinician verification where a medical lead is named.